Hear from the experts about how antibody drug conjugates (ADCs) work, the treatments already approved, and drugs currently in clinical trials.
The panel:
Dr. Kathleen N. Moore, MD, MS, Virginia Kerley Cade Chair in Developmental Therapeutics; Co-Director, Cancer Therapeutics Program, Stephenson Cancer Center, University of Oklahoma
Dr. Gottfried Konecny, MD, Lead Clinician for Gynecologic Oncology in the Department of Medicine at UCLA
Dr. Ramez Eskander, MD, Professor of Gynecologic Oncology
Medical Director of the Clinical Trials Office at
UC San Diego Health and Moores Cancer Center
Clearity Foundation - Scientific and Medical Advisor
Moderated by Dr. Anne Mette Buhl, PhD, Clearity's Director of Science and Clinical Trials
Visit go.clearity.or... for the names of ADCs discuss and additional information about ADCs from Clearity.
Негізгі бет Antibody Drug Conjugates (ADCs): What You Need to Know About This Promising Type of Treatment
Пікірлер